UCART19: Phase I started

Cellectis said Servier and Pfizer began an open-label, U.K. Phase I trial to

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE